Stock Chart

EBS

$6.80 -3.13%
Score: 33.4 EXTENDED
LEAPs: SELL $12
i
LEAPs Option Signal

Type: SELL growth_1yr
Strike: $12
Premium: $1.60
Expiry: Jan 15, 2027
Target: $12
Score: -83

LEAPs are long-term options (1+ year) with less time decay.
Screener
Vol: 1.54x (vs SPY: 0.8x | vs QQQ: 1.0x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Sep 18, 2026
No qualifying chart pattern in the trailing 60 sessions — we only flag setups that pass our quality gate.
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About EBS - Emergent Biosolutions, Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.

Key Statistics

Market Cap $360M

This EBS stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track EBS's price movements with trendlines, gamma walls, and key support/resistance levels.